Neuropsychological Impairment in Children With Class 1 Congenital Heart Disease

Martina Venchiarutti1, Michela Vergine1, Tiziana Zilli2

  • 11 Division of Pediatric, Department of Medicine, University of Udine, Udine, Italy.

Insights

Children with congenital heart disease (CHD) face higher risks for neuropsychological deficits. This study found lower scores in memory, learning, attention, and sensorimotor skills among children with CHD compared to controls.

Area of Science:

  • Pediatric Cardiology
  • Neuropsychology
  • Developmental Pediatrics

Background:

  • Congenital heart disease (CHD) is linked to increased risks of neuropsychological impairments.
  • Nonlinguistic cognitive abilities in children with CHD remain understudied.

Purpose of the Study:

  • To investigate nonlinguistic neuropsychological abilities in school-age children with Class 1 CHD.
  • To compare cognitive functions between children with CHD and matched controls.

Main Methods:

  • Neuropsychological evaluations using the NEPSY II were performed on 17 children with Class 1 CHD and 34 matched controls.
  • Participants had normal intelligence scores and no genetic abnormalities.
  • Children with CHD had undergone at least one cardiac surgery with cardiopulmonary bypass.

Main Results:

  • Children with CHD demonstrated significantly lower scores in memory and learning domains compared to controls.
  • Subtle attention/executive dysfunctions were observed in the CHD group.
  • Deficits in sensorimotor skills were also identified in children with CHD.

Conclusions:

  • Children with Class 1 CHD exhibit specific nonlinguistic neuropsychological deficits, including impaired memory, learning, attention, and sensorimotor skills.
  • These findings highlight the need for targeted neuropsychological assessments and interventions for children with CHD.
  • Cardiac surgery with cardiopulmonary bypass may be associated with these observed cognitive impairments.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
261
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
467
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.0K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
306
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
293
Drug Classes and Categories01:25

Drug Classes and Categories

Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
3.1K